A large analysis has compared how effectively antidepressants prevent symptoms returning after an initial improvement. The BBC reports that escitalopram performed strongly in evidence covering nearly 10,000 patients. BBC News
Key facts
Escitalopram ranked ahead of the other medicines in the analysis, with agomelatine and duloxetine also performing strongly. BBC News
The NHS says antidepressants are usually continued for at least six months after symptoms improve. BBC News
Sleep problems, constipation and weight gain are among the side effects discussed in the BBC report. BBC News
A study of staying well after depression
Escitalopram performed best at preventing relapse in a large comparison of antidepressants, according to research reported by the BBC. The analysis, published in The Lancet Psychiatry, brought together evidence involving almost 10,000 patients and more than a dozen medicines, with follow-up lasting up to a year.
The question was how effectively treatment maintained recovery. That is distinct from asking which drug works fastest when someone first becomes depressed, and the findings do not identify a single best prescription for every patient.
What the ranking found
Escitalopram ranked ahead of the other medicines in the analysis, with agomelatine and duloxetine also performing strongly. Fluoxetine placed lower in the comparison. Researchers and clinicians stressed that the differences were modest and must be weighed against the circumstances of the person taking a medicine.
A ranking summarises outcomes across groups. An individual who has recovered on another treatment may have a good reason to remain on it, particularly when side effects are manageable and the current prescription fits other health needs.
Recovery does not end treatment immediately
The NHS says antidepressants are usually continued for at least six months after symptoms improve. The purpose is to support sustained recovery, rather than stopping medication as soon as someone begins to feel better.
The same guidance explains that medicines can take one to two weeks to start having an effect and up to eight weeks to work fully. The new study's focus on relapse therefore concerns a later phase of treatment than the first weeks of starting a prescription.
Side effects shape the choice
Sleep problems, constipation and weight gain are among the side effects discussed in the BBC report. Different drugs can also interact with other medicines. The NHS notes that people vary in which antidepressants work well for them and which unwanted effects they find easiest to manage.
Selective serotonin reuptake inhibitors are often prescribed first because their side effects are generally easier to manage and they are less likely than some alternatives to cause serious problems in an overdose.
Clinicians put the results in context
Study author Professor Eric Ruhé of Radboud University emphasised shared decisions. Dr Sameer Jauhar of Imperial College London said patients responding well to their present treatment should not assume that the ranking means they need a change.
Professor Allan Young of the Royal College of Psychiatrists similarly highlighted previous response, preferences and side effects. These considerations can matter more to a useful treatment plan than a relatively small average difference between drugs.
Changes need a gradual plan
NHS guidance advises discussing any wish to stop with a doctor and reducing the dose gradually over weeks or months. Withdrawal symptoms can resemble a return of the condition, and some people need a slower reduction than others.
The mental health charity Mind also highlighted talking therapies and support. The study adds evidence to treatment discussions, while leaving space for a broader recovery plan that reflects a person's experience, daily life and access to care.
Questions readers ask
Should a patient switch antidepressants because of this ranking?
A group-level ranking does not determine the best medicine for an individual. The article notes modest differences, side effects and reasons to continue a treatment that is working. Changes should be discussed with a clinician and managed gradually. BBC News
Sources and editorial notes
This article compiles the linked reporting. Allegations, projections and research findings retain their original qualifications; this page does not represent independent field reporting or expert medical review.
- BBC News (reporting)
- NHS: Antidepressants (guidance)
November 17, 2026: Replaced repeated summary and FAQ templates, added source attribution and image description, and clarified the distinction between source publication and site edits. This editorial update is not an independent fact-check certification.



